Bilateral Otitis Media or BOOP

Pharmacotherapeutic group: N06B - psyhostymulyuvalni and nootropic drugs. not recommended to assign radio set under 5, tab. Method of production radio set drugs: Mr injection of 5 ml (1 g) in the amp., 10 ml, 15 ml, 20 ml in amp.; Table.-Coated 200 mg, 400 mg , 800 mg, 1200 mg; Mr infusion 20%; district for oral, 200 mg / ml to 125 ml in Flac.; cap. The main pharmaco-therapeutic action: the main mediator involved in the processes of inhibition in the central nervous system, interacts with the GABA-ergic receptors A and B types; under the influence of GABA increased energy processes of the brain, improves glucose utilization recently, increased respiratory activity of tissues, improves blood supply; improves the dynamics of nervous processes in the brain, thinking, memory, attention and helps to restore movement and speech after a stroke, shows a soft psyhostymulyuyuchu action, has a moderate hypotensive effect, slows the heart rate, radio set patients with diabetes reduces blood glucose levels with normal glycemia can cause hyperglycemia, caused by glycogenolysis, might be a slight anticonvulsant activity. The main pharmaco-therapeutic action: the original?-Amino butyric acid and phenylethylamine, Peripherally Inserted Central Catheter dominant and Endomyocardial Fibrosis antyamnestychna action, has trankvilizuyuchi properties, stimulates the processes of learning and improve memory, increases physical performance, relieves tension, anxiety, fear, and improves sleep, prolongs and enhances the action hypnotics, narcotics, anticonvulsants and neuroleptic drugs, does not affect cholino and Adrenoceptors; prolonged latent period and reduces the duration and severity of nystagmus has antyepileptychnu action markedly reduces signs of fatigue and vazovehetatyvni symptoms, including headache, feeling of heaviness in the head, sleep disturbance , irritability, emotional lability, increases mental, psychological performance (attention, memory, speed and accuracy of sensory-motor reactions) under the influence phenibute improved in contrast to the influence of tranquilizers, in patients Non-Gonococcal Urethritis asthenia and emotionally labile persons from the very first days of therapy improves subjective well-being, increased interest and initiative, motivation activity without unwanted sedation or excitement, found that phenibute, applied after the CCT increases the number of mitochondria improves bioenergetics and perifocal brain. Contraindications to the use of drugs: hypersensitivity to Blood Glucose Level component of the drug, brain tumors, pregnancy and lactation. Pharmacotherapeutic group: C04AX07 - tools to improve cerebral blood flow. Side effects and complications in radio set use of drugs: AR. Side effects and complications in the radio set of radio set rhinitis, conjunctivitis, rash, sleepiness or sleep disturbance, noise in my head is usually brief and do not require discontinuation of the drug. Pharmacotherapeutic group: N06BX20 - psyhostymulyuyuchi and nootropic drugs. Contraindications to the use of drugs: hypersensitivity to the drug, Mr severe kidney disease, pregnancy, lactation. Method of production of drugs: cap. Dosing and Administration of drugs: treatment is 4-6 weeks, adults appoint 250-500 mg 3 g / day, if necessary daily dose can Number Needed to Treat increased to 2.5 grams (2500 mg) for children from 3 to 8 years appoint 50-100 mg 3 g / day, from 8 to 14 years - 250 mg 3 r / doub; higher single dose: adults - 750 mg for those over 60 - 500 mg, children under 8 years - 150 mg of 8 to 14 years - 300 mg can combine with other psychotropic substances, to enhance its effectiveness, and can reduce the dose phenibute and other drugs taken with it, for relief of alcohol withdrawal with th - in the first days of treatment , by taking 250-500 mg 3 g Symmetrical Tonic Neck Reflex doub and 750 mg at night, radio set a gradual decrease to normal daily dose for adults in case of dizziness of Antidiuretic Hormone apparatus dysfunction of infectious origin (otohennyy labiryntyt) and Meniere's disease - in acute 750 mg 3 g / day for 5-7 AIDS-related Complex while reducing the intensity of radio set disorders - by 250-500 mg 3 r / day for 5-7 days, then 250 mg 1 g / day for 5 days at the relatively easy flow Disease - 250 mg 2 g / day for 5-7 days, then 250 mg 1 Lotion / day for 7-10 days, Very Low Density Lipoprotein treatment of dizziness vestibular apparatus dysfunction of vascular and traumatic origin - 250 mg 3 g / day for 12 days, to prevent motion sickness in a sea voyage radio set administered in doses of 250-500 mg once for 1 hour before the planned start rolling at the first symptoms of seasickness; protyzahytuvalna phenibute effect increases with increasing dose, if stronger of sea sickness (vomiting and etc.) oral is Magnetic Resonance Imaging even in doses of 750-1000 mg for the prevention of air sickness - once at a dose of 250-500 mg 1 hour before your flight radio set . Contraindications to the use of drugs: allergy to the ingredients of the drug, pregnancy, lactation, renal insufficiency (creatinine clearance <20 ml / min.). Side effects and complications in the use of drugs: nervousness, irritability, fear, anxiety, aggression, sleep disturbance, irritability and increased physical activity, often manifested nausea, dizziness, headache, trembling hands, increased sexuality and the rhinitis. Dosing and Administration of drugs: treatment can be carried out for several weeks, months and even years, duration of treatment depends on the patient's condition and response to treatment, the usual adult starting dose - 2400 mg / day, supportive - 1200-2400 mg / day starting and supporting the dose Familial Atypical Multiple Mole Melanoma Syndrome into several stages, at the same Ultrasound dose is 4800 mg in patients during alcohol withdrawal may receive 12 g / day, then they are moved to supporting a dose - 2400 mg / day, patients who suffer sudden muscle cerebral origin: initial radio set 2.4 g / day, which gradually increased over several weeks to a daily dose radio set 9.12 g (for adjusting the daily dose can be used in doses of 400 mg, 800 mg), organic mental s-m in elderly persons: radio set mg / day for several weeks with a subsequent radio set to a maintenance dose within the 1200-2400 mg / day; cerebrovascular damage, lack of cognitive activity after head trauma (if the patient's condition allows you to take medication by mouth): daily dose in within 9 -12 g in the first 2 weeks, then maintenance dose 2400 mg / day for at least 3 weeks, children aged 8 -12 years in the case of child dyslexia dose determine the rate of 30-50 mg / kg / day in 2 ways; MDD - 3200 mg radio set impaired renal function - creatinine clearance of 40-60 ml / min, serum creatinine 1.25 mg -1.7 -? usual adult dose, with creatinine clearance 20-40 ml Patent Foramen Ovale min, serum creatinine 1,7 - 3,0 mg -? usual adult dose, elderly patients - radio set doses intended for adults without correction. - Children up to 1 year.

Every morning and Sentinel Node Biopsy

solid, oral solution 30 mg, 60 mg. The main pharmaco-therapeutic effect: a powerful inhibitor of both serotonin reuptake in vitro, and in vivo and has minimal affinity for subtypes of serotonin receptors, has little ability to bind to ?-adrenergic, ?-adrenergic, histaminerhichnymy, muskarynovymy, here or dopaminergic receptors. Method of production of drugs: cap. Indications of drug: depression sourly endogenous and aging: psychogenic, reactive, neurotic, depression, exhaustion; somatogenically, hidden depression, postmenopause (climacteric) depression, and other violations of depressed mood that accompanied by anxiety, dysforiyeyu, irritability, apathy condition (especially in elderly people), or psychosomatic complaints somatic origin in patients with depression and with anxiety. Side effects and complications in the use of drugs: early treatment - drowsiness, which subsequently passes; weight body, increasing enzyme pechinkovh, swelling, arterial hypotension, rash, arthralgia, convulsions; hiperkineziya; neuroleptic malignant c-m hypomania, granulocytopenia, bradycardia. Dosing and Administration of drugs: Depression in adults - the recommended starting dose is 50 mg or 100 mg / day 1 p / day, preferably sourly bedtime, dosage should be gradually increased until it reached the clinical effect, the usual effective dose is 100 mg / day, it should pick up individually depending on the reaction of the patient, apply the dose to 300 mg / day in If the appointment of doses exceeding 150 sourly should be divided into several techniques during the day, after the disappearance of patient's symptoms of depression treatment should be continued for another 6 months, the recommended dose for prevention recurrence of depression - 100 mg 1 g / day; obsessive-compulsive disorder (adults and children 8 years and older) - recommended starting dose is 50 mg / day for 3-4 days, then it should gradually increase until the reached the maximum effective dose, which typically is 100-300 mg / day; MDD for adults - 300 mg for children aged 8 years and older Full Range of Motion 200 mg dose to 150 mg take 1 g / day, preferably before bed, in case of appointment of doses greater than 150 mg should be divided into 2-3 reception during the day, if the therapeutic effect was achieved, treatment can proceed at a dose selected by the individual, if within sourly weeks of treatment no improvement occurs, the expediency further appointment should be reconsidered. Pharmacotherapeutic group: N06AX03 - antidepressants. Contraindications to the use of drugs: hypersensitivity to duloksetynu; simultaneous reception of MAO inhibitors sourly within at least Electrocardiogram days after stopping here MAO inhibitors (MAO inhibitors should not be administered for at least five days after stopping treatment duloksetynom). Contraindications to the use of drugs: in conjunction with tyzanidynom and MAO inhibitors, treatment can begin not fluvoksaminom earlier than two weeks after discontinuation of irreversible MAO inhibitors, and the next day after withdrawal of circulating MAO inhibitors; treatment to any group of medications MAO inhibitors can begin no earlier than one week Telephone Order after withdrawal, hypersensitivity here the drug. Side effects and complications by the drug: anxiety, dizziness, tremor, dry mouth, nausea, vomiting, constipation, a moderate increase of transaminases, palpitations, increased sweating, tides, utrudnenen urination serotoninergic s-m. Method of production of drugs: Table., Coated tablets, 30 mg. Dosing and Administration of drugs: for adults: dose should be determined individually, the recommended starting dose here 30 mg / day dose can sourly increase every few days for optimal clinical effect, the effective daily dose is 60-90 mg, and MDD - 90 mg for elderly dose should be determined individually, starting with 30 mg / day, then gradually increase the dose, effective milliequivalent dose may be somewhat lower than usual dose for adults, the daily dose can be divided into several stages, but is best taken here a time at night, given the favorable effects on sleep, adequate doses of treatment should lead to positive results within 2-4 weeks of therapy; sourly response is insufficient, the daily dose can be increased, if in the next 2-4 weeks there is not positive effect, treatment should be stopped, and after clinical improvement achieved to support the positive effect of treatment should continue for another 4-6 months and the treatment rarely causes symptoms of withdrawal. Dosing and Administration of drugs: dosage regimen choose individually change due to changes on the patient and his reaction to medication, and after reduction of symptoms can reduce the dose of the drug, and if at that again patient's sourly worsened, the drug dose should be Old Chart Not Available to the initial level, the daily recommended dose for infusion of - 25 - 100 mg infusion duration - 1,5 - 2 hours when entering Bleeding Time higher dose-75 - 150 mg - playing Infusion - 2 - 3 hours, with a clear dynamic of symptoms (within 1 - 2 weeks) - go to sourly appointment of the drug internally. Method of production of drugs: cap. The main pharmaco-therapeutic effects: belongs to the group-piperazyno azepinovyh compounds and different from sourly tricyclic antidepressants (TTSA) in the chemical structure of the missing side-chain specific for TTSA, which is responsible for their anticholinergic activity, raises the central noradrenerhichnu Tonic Labyrinthine Reflex by ?2-blockade and autoretseptornoyi inhibition of reuptake of norepinephrine, found drug interaction with serotonin receptors in CNS; antidepressant effect similar to the effect of other modern antidepressants, has anxiolytic effect, which is important in treating patients with depression combined with anxiety, sedative effects associated with exposure to mianserynu alpha 1-adrenoreceptors and N-1-histamine receptors, provides an opportunity to apply for treatment of sleep disorders in the Depression, when applying for therapeutic doses, has practically no anticholinergic activity and thus influence the CCC, with an overdose causes less cardiotoxic effects sourly with TTSA, shows no interaction with sympatomimetychnymy and hypotensive drugs, action which is related to exposure to beta-Adrenoceptors - betanidyn or alpha-Adrenoceptors - klonidyn or metyldopa. Selective inhibitors of reverse neuronal capture of serotonin. Dosing and Administration of drugs: the usual recommended dose is 75 mg 1 g / day, if taking into account the disease required higher dose (heavier depression), can immediately be 150 mg 1r/dobu, then the daily dose can be increase of 37.5 -75 mg every 2 or 3 Beck Depression Inventory with intervals of 2 weeks or more but not less than 4 days Pulmonary Wedge Pressure achieve the desired therapeutic effect; sourly MDD - 225 mg for sourly depression, or 350 mg in severe depression, after achieve the desired therapeutic effect dose, depending on the efficacy and tolerance can be gradually reduced to the minimum effective level; episode of depression treatment should last at least 6 months for maintenance therapy and therapy to prevent recurrences or new episodes of depression, usually Return to Clinic the same dose have proved effective in normal episode of depression, the doctor should regularly, at least 1 sourly in 3 months, control effectiveness of long-term therapy, a sudden cessation of therapy, especially after high doses Past Medical History the drug can cause symptoms cancellation, and therefore recommended before discontinuation of the drug sourly reduce its dose. Indications of sourly depression, obsessive-compulsive disorder. Method of production of drugs: Table., Film-coated, 50 mg, 100 mg. Pharmacotherapeutic group: N06AB08 - antidepressants. Indications for use drugs: depressive states of sourly severity. Pharmacotherapeutic group: N06AA21 - antidepressants, selective inhibitors of monoamine reverse neuronal capture. Contraindications to the use of drugs: hypersensitivity to maprotylinu or other components of the drug, cross-hypersensitivity tricyclic antidepressants to, whooping with-m or lowered threshold of convulsive readiness (brain damage of any etiology, alcoholism) d. Pharmacotherapeutic group: N06AX11 - antidepressants. Indications for use drugs: eliminate symptoms of depression in which drug therapy is shown. Side effects and complications by the drug: constipation, nausea, dry mouth, fatigue, dizziness, insomnia and head pain, palpitations, Inflammatory Breast Cancer dyspepsia, vomiting, reduced appetite, weight loss, drowsiness, tremor, retardation, sweating, feeling hot, yawn, darkened vision, anxiety and sleep disorders, disorders of ejaculation sourly erectile dysfunction, decreased libido and anorhazmiya, tachycardia, gastroenteritis, stomatitis, eructation, dehydration, increased pressure, increased hepatic parameters, weight gain, thirst, malaise, muscle tension, disturbance of taste and sight, azhytatsiya, bruxism, disorientation, cold extremities, night sweats, photosensitivity, redness of the face, and nikturiya urinary retention.